A randomised controlled trial of transdermal versus intramuscular testosterone therapy in transgender males

Research Opportunity
PhD
Number of Honour Places Available
1
Department
Medicine and Radiology
Location
Austin Health
Supervisor Email Number Webpage
Jeffrey Zajac j.zajac@unimelb.edu.au 90357030 Personal web page
Ada Cheung adac@unimelb.edu.au 94962260 Personal web page

Project Details

This is a randomised controlled trial comparing the safety of intramuscular vs transdermal testosterone on haematocrit in transgender males. Testosterone can increase haematocrit (blood thickness) and raised haematocrit levels have been associated with increased cardiovascular mortality, the risk of which is higher in biological females than biological males. It is uncertain whether haematocrit levels in transgender males are associated with adverse cardiovascular risk.

The project is based at Heidelberg Repatriation Hospital (part of Austin Health) within the Trans Medical Research Group, Endocrinology Department (Department of Medicine).



Faculty Research Themes

Neuroscience

School Research Themes

Neuroscience & Psychiatry, Cardiometabolic



Research Opportunities

PhD
Students who are interested in joining this project will need to consider their elegibility as well as other requirements before contacting the supervisor of this research

Graduate Research application

Honours application

Key Contact

For further information about this research, please contact a supervisor.

Department

Medicine and Radiology

Research Node

Austin Health

MDHS Research library
Explore by researcher, school, project or topic.